Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Litigation Management Comments

Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing FacilityAugust 15, 2018 6:00 AM Paulson's 13F Shows New Stakes in Akorn (AKRX), AT&T (T), Mitel (MITL), Increase in Discovery (DISCA) (More...) August 14, 2018 5:14 PM Endo International plc (ENDP) PT Raised to $17 at Mizuho SecuritiesAugust 14, 2018 5:46 AM Endo International (ENDP): Vasopressin Headlines Likely Worse than Reality - CitiAugust 13, 2018 1:30 PM Endo International (ENDP) Weakness on Compounded Vasopressin Launch Bears Watching FDA Action - RBCAugust 13, 2018 11:39 AM Endo International plc (ENDP) PT Raised to $16 at BMO CapitalAugust 13, 2018 8:26 AM RBC Capital Upgrades Endo International plc (ENDP) to Outperform on Cycle Up-TurnAugust 13, 2018 4:51 AM